Supreme Court ruling on penalty clauses: consequences for bad leaver provisions
Facing up to antimicrobial resistance – recommendations from the O'Neill review
Largest damages award on cross-undertaking upheld on appeal
EU Commission regulates post-authorisation efficacy studies ("PAES")
Personalised medicine – challenges of authorisation and reimbursement
There is more than one way to extend data exclusivity periods
What the new Customs Regulation means in practice